Axonics Inc is a medical technology company that specializes in the development and commercialization of innovative solutions for the treatment of urinary and bowel dysfunction
The company focuses on neurostimulation therapy, offering sacral neuromodulation devices designed to improve the quality of life for patients suffering from conditions such as overactive bladder, urinary incontinence, and fecal incontinence. Through its commitment to advanced medical technology and patient-centered care, Axonics aims to provide effective and minimally invasive treatment options that enhance the overall health and well-being of individuals affected by these disorders.
Boston Scientific announces a Class I recall of Obsidio Embolic due to high-risk implications for lower GI bleeding embolization. Potential adverse effects include bowel ischemia, necessitating major surgery or resulting in prolonged hospitalization.
Shares of RxSight, Inc. (NASDAQRXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on the stock and raised its price target from $35 to $41.
